Orthopedic Prosthetics Market Trend Analysis by Smith and Nephew, Touch Bionics Inc, Zimmer Boimet Holdings Inc., Stryker Corp – Jewish Life News

GlobalOrthopedic Prosthetics MarketBy Product Type (Upper Extremity Prosthetics (Hand Prosthetics, Elbow Prosthetics, Shoulder Prosthetics), Lower Extremity Prosthetics (Foot & Ankle Prosthetics, Knee Prosthetics, Hip Prosthetics), Liners, Sockets, Modular Components); Technology (Manual Prosthetics, Electric Powered Prosthetics, Hybrid Prosthetics); End User (Hospitals, Clinics, Rehabilitation Centers, and Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) Industry Trends & Forecast to 2026

Global Orthopedic Prosthetics Market is expected to rise from its initial estimated value of USD 2.11 billion is 2018 to an estimated value of USD 3.24 billion by 2026, registering a CAGR of 5.5% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing number of amputations leading to use of orthopedic prosthetic devices.

Few of the major competitors currently working in the orthopedic prosthetics market are Blatchford Group (UK), Touch Bionics Inc. (US), The Ohio Willow Wood Co. (US), ssur (Iceland), Ottobock (Germany), Fillauer LLC. (US), Advanced Arm Dynamics, inc. (US) Smith and Nephew (UK), Touch Bionics Inc (US)., Zimmer Boimet Holdings Inc. (US), Stryker Corp (US) DePuy Synthes (US). Blatchford Ortopedi AS (Norway), Exactech, Inc (US) Globus Medical Inc, (US), RTI Surgical Inc (US), Wright Medical Group N.V.,(US), Johnson & Johnson Services, Inc. (US), Arthrex Inc,(US), AlloSource (US) and others.

Get Sample Report @https://databridgemarketresearch.com/request-a-sample/?dbmr=global-orthopedic-prosthetics-market

Key Developments in the Market:

Cell and Gene Therapy Digital Conference| Register at:https://www.databridgemarketresearch.com/digital-conference/cell-and-gene-therapy

Competitive Analysis: Global Orthopedic prosthetics Market

Global orthopedic prosthetics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of orthopedic prosthetics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Definition: Global Orthopedic prosthetics Market

Orthopedic Prosthetics is an artificial replacement or substitute of bones in different parts of the body. The typical orthopedic prosthetic devices are for hip, knee, elbow, ankle, leg among others.

According to Stanford Childrens Health, there were an estimated 3.5 million sports injuries occurred, this significant number is expected to act as a driver to the market growth.

Request for Detailed TOC @https://databridgemarketresearch.com/toc/?dbmr=global-orthopedic-prosthetics-market

Market Drivers

Market Restraints

Segmentation: Global Orthopedic prosthetics Market

By Product Type

By Technology

By End User

By Geography

Reasons to Purchase this Report

Customization of the Report:

Order a Copy of This Research Report @https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-orthopedic-prosthetics-market

Continued here:
Orthopedic Prosthetics Market Trend Analysis by Smith and Nephew, Touch Bionics Inc, Zimmer Boimet Holdings Inc., Stryker Corp - Jewish Life News

Brain Tumor Treatment Market 2020 Review, Future Growth, Global Survey, impact of COVID-19 on Indepth Analysis, Share, Key Findings, Company Profiles,…

Global Brain Tumor Treatment Market 2020 research report includes an outline of the business with industrial chain structure, applications, and prominent insights. Additionally, it provides details regarding the global market consisting of vital locales, their improvement techniques, focused scene investigation, and patterns of advancements. State-of-the-art plans and approaches are observed just as assembling cost structures and procedures are dissected likewise. Brain Tumor Treatment Market report further mentions the gross productivity, income, value, cost, market figures, as well as trade utilities or imports.

Get a Sample PDF of report at https://www.researchreportsworld.com/enquiry/request-sample/15489399

The global Brain Tumor Treatment market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026. In 2020, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

The Global Brain Tumor Treatment market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Brain Tumor Treatment Market Share analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.

Final Report will add the analysis of the impact of COVID-19 on this industry.

Under COVID-19 Outbreak, how the Brain Tumor Treatment Industry will develop is also analyzed in detail in Chapter 1.7 of the report. In Chapter 2.4, we analyzed industry trends in the context of COVID-19 for Brain Tumor Treatment Market. In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets for Brain Tumor Treatment Market. In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries on Brain Tumor Treatment Market. In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

To Understand How COVID-19 Impact is Covered in This Report. Get Sample copy of the report at https://www.researchreportsworld.com/enquiry/request-covid19/15489399

The report can help to understand the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Brain Tumor Treatment industry.This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. For each manufacturer covered, this report analyzes their Brain Tumor Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

Global Brain Tumor Treatment Market Report 2020 provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Enquire before purchasing this report https://www.researchreportsworld.com/enquiry/pre-order-enquiry/15489399

List Of TOP KEY PLAYERS in Brain Tumor Treatment Market Report are

Get a Sample Copy of the Brain Tumor Treatment Market Report 2020

The report also focuses on global major leading industry players of Global Brain Tumor Treatment Market Share providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. With tables and figures helping analyse worldwide Global Brain Tumor Treatment Market Forecast this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

The Global Brain Tumor Treatment Market Trends, development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.

Purchase this report (Price 3400 USD for single user license) https://www.researchreportsworld.com/purchase/15489399

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Some of the key questions answered in this report:

Major regions covered in the report:

Major Points from Table of Contents:

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Brain Tumor Treatment Market Share by Type (2020-2026) 1.5.2 Tissue Engineering 1.5.3 Immunotherapy 1.5.4 Gene Therapy 1.5.5 Other Therapies 1.6 Market by Application 1.6.1 Global Brain Tumor Treatment Market Share by Application (2020-2026) 1.6.2 Hospitals and Clinics 1.6.3 Treatment Center 1.6.4 Others 1.7 Brain Tumor Treatment Industry Development Trends under COVID-19 Outbreak 1.7.1 Region COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Brain Tumor Treatment Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porters Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 3 Value Chain of Brain Tumor Treatment Market 3.1 Value Chain Status 3.2 Brain Tumor Treatment Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Brain Tumor Treatment 3.2.3 Labor Cost of Brain Tumor Treatment 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 4 Players Profiles 4.1 Macleods Pharmaceutical Limited 4.1.1 Macleods Pharmaceutical Limited Basic Information 4.1.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.1.3 Macleods Pharmaceutical Limited Brain Tumor Treatment Market Performance (2015-2020) 4.1.4 Macleods Pharmaceutical Limited Business Overview 4.2 Antisense Pharma 4.2.1 Antisense Pharma Basic Information 4.2.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.2.3 Antisense Pharma Brain Tumor Treatment Market Performance (2015-2020) 4.2.4 Antisense Pharma Business Overview 4.3 Merck & Co 4.3.1 Merck & Co Basic Information 4.3.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.3.3 Merck & Co Brain Tumor Treatment Market Performance (2015-2020) 4.3.4 Merck & Co Business Overview 4.4 Pfizer, Inc. 4.4.1 Pfizer, Inc. Basic Information 4.4.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.4.3 Pfizer, Inc. Brain Tumor Treatment Market Performance (2015-2020) 4.4.4 Pfizer, Inc. Business Overview 4.5 Hoffmann- La Roche 4.5.1 Hoffmann- La Roche Basic Information 4.5.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.5.3 Hoffmann- La Roche Brain Tumor Treatment Market Performance (2015-2020) 4.5.4 Hoffmann- La Roche Business Overview 4.6 Genetech U.S.A 4.6.1 Genetech U.S.A Basic Information 4.6.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.6.3 Genetech U.S.A Brain Tumor Treatment Market Performance (2015-2020) 4.6.4 Genetech U.S.A Business Overview 4.7 Bristol Myers Squibb 4.7.1 Bristol Myers Squibb Basic Information 4.7.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.7.3 Bristol Myers Squibb Brain Tumor Treatment Market Performance (2015-2020) 4.7.4 Bristol Myers Squibb Business Overview 4.8 Novartis AG 4.8.1 Novartis AG Basic Information 4.8.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.8.3 Novartis AG Brain Tumor Treatment Market Performance (2015-2020) 4.8.4 Novartis AG Business Overview 4.9 AstraZeneca plc 4.9.1 AstraZeneca plc Basic Information 4.9.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.9.3 AstraZeneca plc Brain Tumor Treatment Market Performance (2015-2020) 4.9.4 AstraZeneca plc Business Overview 4.10 Dr. Reddys Laboratories Ltd 4.10.1 Dr. Reddys Laboratories Ltd Basic Information 4.10.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.10.3 Dr. Reddys Laboratories Ltd Brain Tumor Treatment Market Performance (2015-2020) 4.10.4 Dr. Reddys Laboratories Ltd Business Overview 4.11 Mankind Pharma 4.11.1 Mankind Pharma Basic Information 4.11.2 Brain Tumor Treatment Product Profiles, Application and Specification 4.11.3 Mankind Pharma Brain Tumor Treatment Market Performance (2015-2020) 4.11.4 Mankind Pharma Business Overview 5 Global Brain Tumor Treatment Market Analysis by Regions 5.1 Global Brain Tumor Treatment Sales, Revenue and Market Share by Regions 5.1.1 Global Brain Tumor Treatment Sales by Regions (2015-2020) 5.1.2 Global Brain Tumor Treatment Revenue by Regions (2015-2020) 5.2 North America Brain Tumor Treatment Sales and Growth Rate (2015-2020) 5.3 Europe Brain Tumor Treatment Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Brain Tumor Treatment Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Brain Tumor Treatment Sales and Growth Rate (2015-2020) 5.6 South America Brain Tumor Treatment Sales and Growth Rate (2015-2020)

Continued

Browse complete table of contents at https://www.researchreportsworld.com/TOC/15489399

About Us:

Research Reports World is the credible source for gaining the market reports that will provide you with the lead your business needs. At Research Reports World, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:

Name: Ajay More

Email: [emailprotected]

Phone: US+1424 253 0807/UK+44 203 239 8187

Other Reports Here:

Healthcare Analytics/Medical Analytics Market Size, Share, Business Revenue, Future Growth, Trends Plans, Top Key Players, Business Opportunities, Industry Analysis by Forecast to 2026 Research Reports World

Spectrophotometers Market Size, Global Industry Share, Trends, Sales Revenue, Industry Growth, Development Status, Top Leaders, Future Plans and Opportunity Assessment 2026

Healthcare Analytical Testing Services Market Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2026 Available at Research Reports World

Speaker Materials Market Size Global Industry Analysis by Trends, Share, Company Overview, Growth and Forecast by 2026 Latest Research Report by Research Reports World

Interventional Radiology Market Size Research Report to 2026 Industry, Growth Share, Future Trends, Price, Top Key Players Review, Business Opportunities, Demand and Global Analysis by Forecast

Go here to read the rest:
Brain Tumor Treatment Market 2020 Review, Future Growth, Global Survey, impact of COVID-19 on Indepth Analysis, Share, Key Findings, Company Profiles,...

Vision Care Market Size Projection, Cost Structure Analysis, Sales Statistics, Growth Estimation and Industry Insights By 2025 – Daily Research…

Vision Care Market Overview:

The Global Vision Care Market size is on a path to grow beyond USD 70,818.48 Million valuation by 2025 at a CAGR of 4.48% during the forecast period of 2019 to 2025. Market Research Future (MRFR) reveals several aspects of the global market like the growing geriatric population, increasing awareness about refractive errors, better technological inclusion, hike in investment, and others are expected to set the vision care market in motion. However, the vision care market may find some distraction in the form of complications regarding contact-lens.

OneSight, a non-profit organization, launched a free software that could be used online to assess whether children have refraction error or not. This tool is so simple that parents can easily engage their kids to check for various errors and color-related problems. The tool is expected to raise significant awareness among parents regarding vision care. This process will hardly take minutes to deliver results.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8450

Vision Care Market Segmentation:

MRFR made an assessment of the global vision care market by having it segmented into product type, end user, indication, and treatment. These segments and their insights based on the factors and dynamics motivating the segmental moves have been charted well to get a closer look at the global market progress.

By product type, the report on the vision care market can be segmented into a contact lens, eyeglasses, intraocular lens (IOL), contact lens solution, and others. The contact lens segment includes a therapeutic lens, cosmetic, corrective lens, and lifestyle-oriented lens. The eyeglasses segment dominates the market, and it is sub-segmented into Single Vision, Progressive, Bifocal, and Sunglasses. The IOL segment includes traditional/mono-focal, premium, and phakic.

By indication, the global vision care market care can be segmented into refractive error, glaucoma, diabetic retinopathy, amblyopia, dry eyes, and others. The refractive error segment is quite common. The dry eyes segment is also common as the malfunctioning of tear glands happen to a lot of people.

By treatment, the global vision care market can be segmented into surgery, medication, laser therapy, and others. The surgery part can be sub-segmented into cornea transplant, vitrectomy, and cataract surgery. It has the maximum market share. The medication segment includes acetylcysteine, gentamicin, acetazolamide, and others.

By end user, the global vision care market can be segmented into eye hospitals & clinics, optical stores, ambulatory surgery centers, and others. The eye hospitals and clinics segment have a dominating role in the market.

Vision Care Market Regional Analysis:

Technological superiority, better infrastructure, and investment flow, high awareness is some of the reasons that will establish the American vision care market at the forefront. In Europe, the same type of growth will be witnessed. The Asia Pacific region will be the fastest-growing one among all.

Browse Full Report Details at: https://www.marketresearchfuture.com/reports/vision-care-market-8450

Vision Care Market Competitive Landscape:

The global vision care market has several companies to bolster growth. These companies are The Cooper Companies, Inc [US] (Cooper Vision), ESSILORLUXOTTICA (France), Bausch Health [Canada] (Bausch & Lomb Incorporated), Johnson & Johnson Services, Inc. (US), NOVARTIS AG (Switzerland), Cadila Healthcare [India] (Zydus Pharmaceuticals, Inc.), Menicon (Japan), Rayner Surgical Group Limited [UK] (Rayner Intraocular Lenses Limited), and Carl-Zeiss-Stiftung [Germany] (Carl Zeiss). These companies have invested their brain, time, and money in developing top-class strategies to increase their profit margin. Mergers, acquisitions, marketing strategies, better innovations, increasing expenditure for the research and development sector, and others are factors that play a crucial part in helping companies with strategies. MRFR made a note of their recent contributions to the market to get a decent overview of how the market is planning to move forward.

Browse More Related Reports at:

Gene Therapy Market

Psoriasis Treatment Market

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [emailprotected]

Read the rest here:
Vision Care Market Size Projection, Cost Structure Analysis, Sales Statistics, Growth Estimation and Industry Insights By 2025 - Daily Research...

Osteoarthritic Pain Management Treatment Market Trend Analysis by Boehringer Ingelheim International GmbH, Abbott, AbbVie Inc., Astellas Pharma -…

Global Osteoarthritic Pain Management Treatment Market, By Type (Hip, Wrist, Spinal, Others), Diagnosis (Imaging), Treatment (Medication, Surgery, Therapy, Others), End-Users (Hospitals, Clinics, Medical Institutes, Research) By Region (North America, South America, Europe, Asia-Pacific, Middle East and Africa) Forecast to 2025

Major players analysis covered Pfizer Inc., AstraZeneca, Medivation Inc., Eli Lilly and Company, Abiogen Pharma S.p.A., Merck Sharp & Dohme Corp., Novartis AG, GlaxoSmithKline plc., Zimmer Biomet, Abbott Laboratories, Johnson & Johnson Services, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Abbott, AbbVie Inc., Astellas Pharma, BioDelivery Sciences International LLC., Crystal Genomics, Daiichi-Sankyo Company Limited, Endo Pharmaceuticals Inc., among others are the major Market players.

Download PDF Sample Copy of Report @https://databridgemarketresearch.com/request-a-sample/?dbmr=global-osteoarthritic-pain-management-treatment-market

Market Analysis:

Increase in the number of cases of Osteoarthritis is the rise in the geriatric population all over the world. This has left the industry with plenty of room to grow, because of the fact that there are no particular treatments available in the markets that are effective.

Cell and Gene Therapy Digital Conference| Register at:https://www.databridgemarketresearch.com/digital-conference/cell-and-gene-therapy

Market Definition:

Osteoarthritis is a type of joint disorder that attacks the cartilage in between the bones and makes the joints swell up, red in color and making difficult for the joints to move properly. The usual symptoms of it are swelling, decrease in range of motion, and immobility in arms and legs specially when the spine is affected with osteoarthritis. All of the usual daily activities are affected.

Market Drivers

Market Restraints

Order a Copy of Osteoarthritic Pain Management Treatment Market Report @https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-osteoarthritic-pain-management-treatment-market

Market Segmentation:

Type

Diagnosis (Imaging)

Treatment

End-Users

Region

Competitive Analysis: Global Osteoarthritic Pain Management Treatment Market

The GlobalOsteoarthritic Pain Management Treatment marketis highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Osteoarthritic Pain Management Treatment market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Customization of the Report

View Full Report @https://databridgemarketresearch.com/reports/global-osteoarthritic-pain-management-treatment-market/

Read the original here:
Osteoarthritic Pain Management Treatment Market Trend Analysis by Boehringer Ingelheim International GmbH, Abbott, AbbVie Inc., Astellas Pharma -...

Impact on COVID-19 Medical Tapes and Bandages Industry : Identify the types of companies that could potentially benefit from the impact of COVID-19 |…

Global Medical Tapes and Bandages Market, By Product (Medical Bandages, Medical Tapes), By Application (Surgical Wound Treatment, Traumatic Wound Treatment, Ulcer Treatment, Sports Injury Treatment, Burn Injury Treatment, Others), By End User (Hospitals, Ambulatory Surgery Centers, Clinics, Home Care Settings) By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) and Forecast to 2025.

Global Medical Tapes and Bandages Market is expected to reach USD 7.90 billion by 2025, from USD 6.18 billion in 2017 growing at a CAGR of 3.6% during the forecast period of 2018 to 2025.

Get Sample Copy @http://databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-tapes-bandages-market

Cell and Gene Therapy Digital Conference| Register at:https://www.databridgemarketresearch.com/digital-conference/cell-and-gene-therapy

Major Market Competitors/Players:

3M

Medtronic

Derma Sciences Inc.

Johnson & Johnson Consumer Inc.

Cardinal Health, Inc.

Smith & Nephew

Medline Industries, Inc.

B Braun Melsungen AG

Paul Hartman AG

Beiersdorf

Nitto Denko Corporation

BSN Medical

Mlnlycke Health Care

Andover Healthcare Inc.

Nichiban Co., Ltd.

Dukal Corporation

Dynarex Corporation

Lohmann & Rauscher

Avcor Health Care Products, Inc

Aso Medical

Tetra Medical Supply Corporation

Amd Medicom Inc.

Kerma Medical Products Inc.

Walgreens

Dermarite Industries, LLC.

Among others.

Global Medical Tapes and Bandages Market

By Product (Medical Bandages, Medical Tapes),

By Application (Surgical Wound Treatment, Traumatic Wound Treatment, Ulcer Treatment, Sports Injury Treatment, Burn Injury Treatment, Others),

By End User (Hospitals, Ambulatory Surgery Centers, Clinics, Home Care Settings),

By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Major Market Drivers and Restraints:

Rising geriatric population base resulting in increasing incidence of chronic illness and injuries.

Increasing incidence of pressure ulcer, diabetic foot and surgical procedures

Escalating incidence of wound infection

High cost

Adverse effect on skin

Competitive Analysis:

The global medical tapes and bandages market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of medical tapes and bandages market for global, Europe, North America, Asia Pacific and South America.

Market Definition:

Medical tapes are the pressure sensitive adhesive tapes used for supporting bandage and other wound dressings. Medical bandages are a cotton gauge cloth beneficial for supporting medical devices such as surgical dressing or splint. They are used to maintain moisture at site of dressing, promote wound healing and provide mechanical & bacterial protection to the wound. The demand for these are increasing in various application like surgical wound treatment, traumatic wound treatment, ulcer treatment, sports injury treatment and burn injury treatment. According to United Nation Population Fund (UNFPA), the population above 60 and more involve more than the 12.3% of global population and by 2050 it may rise to reach around 20% of global population. Due to growing geriatric population, the cases of acute and chronic diseases are rising. Rising elderly populace and along with increasing chronic disorders will help in the growth of medical tapes and bandages industrial demand.

Have Any Query? Ask Ours Expert @http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-medical-tapes-bandages-market

Report Segmentation:

Based on product:

Medical bandages market segment is further sub segmented into:

Medical tapes segment is further sub segmented into:

On the basis of application:

On the basis of end-user:

Based on geography:

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Read more about the Global Medical Tapes and Bandages Market Visit @http://databridgemarketresearch.com/reports/global-medical-tapes-bandages-market/

About Us:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.Get 10% Discounton Report by emailing[emailprotected]. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email:[emailprotected]

Read the original post:
Impact on COVID-19 Medical Tapes and Bandages Industry : Identify the types of companies that could potentially benefit from the impact of COVID-19 |...

Choroideremia Treatment Market Share Analysis by Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc – Daily Research Advisor

Global choroideremia treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global choroideremia treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Data Bridge Market Researchhas added an exhaustive research study of theGlobal Choroideremia Treatment Marketdetailing every single market driver and intricately analyzing the business vertical. The research report has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The research report presents a complete assessment of the market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data.

Global Choroideremia Treatment Marketis expected to grow at a steady CAGR in the forecast period of 2019-2026.Increase in strategic alliances between the pharmaceuticals companies and high demand of disease specific novel therapies are the key factors that fueling the market growth. Global Choroideremia Treatment Market By Treatment Type (Gene Therapy, Surgery), Route of Administration (Oral, Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Ophthalmic Clinics and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) Forecast to 2026

Download exclusive PDF sample report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-choroideremia-treatment-market

Key Developments in the Market:

Reasons to Purchase this Report

Order a Copy of Global Choroideremia Treatment Market Report @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-choroideremia-treatment-market

Some of the major competitors currently working in the global choroideremia treatment market areBiogen, 4D Molecular Therapeutics, Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc, PIXIUM VISION, Retina Implant AG, F. Hoffmann-La Roche Ltd and others.

Market Definition:

Choroideremia is also known as choroidal sclerosis is a rare, degenerative, X-linked inherited retinal disorder characterized by progressive degeneration of the choroid, retinal pigment epithelium (RPE) and retina due to Mutations in the CHM gene. This CHM gene required to produce Rab escort protein-1 (REP-1). The condition gets its name from the distinctive sweet odor of affected infants urine and is also c, a protein that takes part in targeting vesicles (small sacs of substances) into, out of, and within cells.

According to the statistics published by U.S. Department of Health & Human Services, an estimated population of choroideremia is about 1 in 50,000-100,000 people. Presence of refined healthcare infrastructure and emerging new market are the key factors for growth of this market.

Market Drivers

Market Restraints

Segmentation:Global Choroideremia Treatment Market

By Treatment

By Route of Administration

By End Users

By Distribution Channel

ByGeography

Download Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-choroideremia-treatment-market

The rest is here:
Choroideremia Treatment Market Share Analysis by Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc - Daily Research Advisor

Magnetic Resonance Imaging (MRI) Market Applications, Future Trends, Size Value, Growth Statistics, Sales Projection and COVID-19 Impact Analysis By…

(MENAFN - iCrowdNewsWire) Jul 13, 2020

Magnetic Resonance Imaging (MRI) Market Size, Growth and Share Analysis By Field Strength (High-Field MRI Systems), Type (Close MRI and Open MRI), Disease Application (Brain and Neurological MRI), Regional Outlook and End-Users Forecast to 2023

Magnetic Resonance Imaging (MRI) Market Overview

The magnetic resonate particles are the radio waves that provides the three-dimensional images of the internal organs and joints in the body. MRI shows you the detailed structure of the organ without any invasive surgery. It also detects the heart, surrounding view of the artery and the troubles related to it. MRI study also involves Brain MRI, individual organ MRI and the extremities. The MRI market works on four demands. The Global Magnetic Resonance Imaging (MRI) Market size is anticipated to reach USD 5 billion at a CAGR of 3.5% by the end of 2023, says Market Research Future (MRFR). MRI is a non-invasive diagnostic technology that produces digital images of the internal body structures. It uses the magnetic resonate atoms to show the pictures of the inner body tissue and organs.

The four applications of magnetic resonance imaging market include the non-invasive procedure in practices, the harmful effects of the radiation-based imaging, rising in the research and development of the life science and the increasing use of magnetic resonance imaging in the drug discovery.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6194

There are certain other factors also that fuel the growth of the MRI market. The primary factor that is increasing the demand for MRI is the increase in the geriatric population. The increase in the geriatric population leads to the rise of cardiovascular, neurological and ophthalmic disorders which results in the growth of the MRI market. However, certain factors affect the growth of magnetic resonance imaging market such as high cost of the instruments, strict regulatory, insufficient reimbursement policies and the lack of skilled operators.

Magnetic Resonance Imaging (MRI) Market Segmentation

The global magnetic resonance imaging market is segmented into four types.

Based on the magnetic field strength, the magnetic resonance imaging market is divided into four types

Based on the architectural model, the MRI market is of two kinds;

based on its application, the global magnetic resonance imaging market is classified into four types. The segmentation includes

The MRI market is also segmented based on end-users that include

As of now, the medium and the high-field segments are having large scale adoption. Usually, the medium and high-field sections produce better image quality to the end-users that helps in better treatment of the disease. The increasing demand for MRI in the hospitals and clinics is rising with the highest MRI market share. The MRI market is one of the significant markets for investment.

Magnetic Resonance Imaging (MRI) Market Regional Outlook

Magnetic Resonance Imaging Market Competitive Landscape:

The global magnetic resonance imaging (MRI) market is getting boosted by the strategic decisions of several companies like Siemens AG, Hitachi, GE Healthcare, Canon Medical Systems, Toshiba Corporation, Philips, Xingaoyi, Toshiba Corporation, and Aurora Imaging Technologies, Inc. These companies are planning mergers, acquisitions, collaborations, and others to ensure their own stand in the market. Their growing investment in the research and development sector is promoting healthy competition, which could ensure a better growth rate in the coming years.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/magnetic-resonance-imaging-market-6194

Magnetic Resonance Imaging (MRI) Market News

Browse More Healthcare Research Reports at:

Structural Heart Devices Market: Type (Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems), Indication (Valvular Heart Disease, Cardiomyopathy), Procedure (Replacement Procedures, Repair Procedures)Global Forecast Till 2023

https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385

mHealth Market Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) By Application(monitoring, diagnosis & treatment, wellness & prevention) - Forecast to 2022

https://www.marketresearchfuture.com/reports/mobile-health-market-1816

Gene Editing Market Research Report, By Methods (Crispr, Talen, Zfn, Antisense Technology And Others), By Applications (Plant Genetic Engineering, Animal Genetic Engineering, Gene Therapy, Microorganisms Genetic Engineering), By End User (Biotechnology, Pharmaceutical, Contract Research Organization) Global Forecast Till 2023

https://www.marketresearchfuture.com/reports/gene-editing-market-707

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

View post:
Magnetic Resonance Imaging (MRI) Market Applications, Future Trends, Size Value, Growth Statistics, Sales Projection and COVID-19 Impact Analysis By...

Anastomosis Device Market Size, Product, Application, Trends, Growth Opportunities, Analysis and Forecast to 2027 – Daily Research Chronicles

Global Anastomosis Device Marketanalysis report is also helpful in assessing the effectiveness of advertising programme and to know the causes of consumer resistance. The market report also contains the drivers and restraints for theAnastomosis Device Marketthat are derived from SWOT analysis, and also shows what all the recent developments, product launches, joint ventures, mergers and acquisitions by the several key players and brands that are driving the market are by systemic company profiles.

Anastomosis device marketis expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3581.30 million by 2027 growing at a CAGR of 6.9% in the above-mentioned forecast period. Growth in healthcare industry and increasing number of gastrointestinal & urological surgery procedures are further creating new opportunities for the market in the forecast period of 2020 to 2027.

Global Anastomosis Device Market By Product (Surgical Staplers, Surgical Sutures, Surgical Sealants & Adhesives), Application (Gastrointestinal Surgeries, Cardiovascular & Thoracic Surgeries, Other), End- Users (Hospitals, Ambulatory Surgery Centers & Clinics), Product Type (Disposable, Reusable), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa), Market Share Forecast to 2027

Request a Sample Report of Global Anastomosis Device Market @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-anastomosis-device-market

Cell and Gene Therapy Digital Conference| Register at:https://www.databridgemarketresearch.com/digital-conference/cell-and-gene-therapy

The major players covered in the anastomosis devicereport areMedtronic, Medical Devices Business Services, Inc., B. Braun Melsungen AG, EndoEvolution, LLC., CryoLife, Intuitive Surgical, Inc, Boston Scientific Corporation., SYNOVIS MICRO COMPANIES ALLIANCE, INC, Biosintex, Meril Life Sciences Pvt. Ltd., AesDex, LLC, Vitalitec., AesDex, LLC, Getinge AB,among other players domestic and global. Market Share data is available for Global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market Analysis and Insights:Global Anastomosis Device Market

Anastomosis is an operational link between two tubular structures, such as blood vessels or intestinal loops. Anastomosis devices are widely used during the gastrointestinal and cardiac surgeries. Some of the common types of the anastomosis devices are surgical staplers, surgical sutures, and surgical sealants & adhesives.

Increasing demand for minimally invasive procedures will enhance the market demand in the market. Growing number of surgical procedures and increasing prevalence of chronic diseases is also expected to enhance the market position in the market. There is also availability of favourable reimbursement structure and advancement & development in the products will also accelerate the demand for anastomosis devices in the market. On the other hand, increasing prevalence of CVD is also expected to create new opportunities for the anastomosis devices market in the forecast period of 2020- 2027

Anastomosis device market report provides details of market share, new developments, product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for anAnalyst Briefour team will help you create a revenue impact solution to achieve your desired goal.

Global Anastomosis Device Market Scope and Market Size

Anastomosis device market is segmented of the basis of product, application and end- users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on product, the anastomosis device market is segmented into surgical staplers, surgical sutures, and surgical sealants & adhesives. The surgical staplers segment is divided into manual surgical staplers, and powdered surgical staplers. Surgical sutures are sub- segmented into absorbable sutures, non-absorbable sutures, and automated suturing devices. The absorbable sutures are further divided into synthetic sutures and natural sutures. Synthetic sutures is divided into polyglactin 910 sutures, poliglecaprone 25 sutures, polyglycolic acid sutures, polydioxanone sutures, and other. The non- absorbable sutures are divided into polypropylene sutures, nylon sutures, stainless steel sutures, and other. Automated suturing devices are segmented into disposable automated suturing devices and reusable automated suturing devices. Surgical sealants & adhesives is further categorized into natural/biological surgical sealants and adhesives, and synthetic and semisynthetic sealants and adhesives. Natural/biological surgical sealants and adhesives is segmented into fibrin-based sealants & adhesives, collagen-based sealants and adhesives, and albumin-based sealants and adhesives. The synthetic and semisynthetic sealants and adhesives is further segmented into peg hydrogel-based sealants and adhesives, cyanoacrylate-based sealants and adhesives, urethane-based sealants and adhesives, and other.

Based on application, the anastomosis device market is segmented into gastrointestinal surgeries, cardiovascular & thoracic surgeries, and other.

Anastomosis device market is also segmented on the basis of end- users as hospitals, and ambulatory surgery centers & clinics.

For More Details In-Depth Inquiry @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-anastomosis-device-market

Anastomosis Device Market Country Level Analysis

Anastomosis device market is analysed and market size insights and trends are provided by type, application, and end- users as referenced above.

The countries covered in the anastomosis device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America.

North America dominates the anastomosis device market due to the high prevalence of tcancer patients, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period 2020 to 2027 due to increasing number of hospitals, improvement in healthcare infrastructure, and increasing ageing population.

The country section of the anastomosis devicereport also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Anastomosis device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for anastomosis device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the anastomosis device market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Anastomosis Device Market Share Analysis

Anastomosis device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, proovals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies focus related to anastomosis device market.

Customization Available:Global Anastomosis Device Market

Data Bridge Market Researchis a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

View Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-anastomosis-device-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

Read the original:
Anastomosis Device Market Size, Product, Application, Trends, Growth Opportunities, Analysis and Forecast to 2027 - Daily Research Chronicles

Hemophilia Treatment Market Size & Share 2020 Research Report Covering COVID-19 Impact on Growth Analysis and Outlook till 2026 – Red & Black…

Hemophilia Treatment Market Report 2020-26: COVID-19 Impact Analysis, Growth, and Change by Facts and Factors provide the strategists, marketers, and senior management with the critical information they need to assess the Hemophilia Treatment market.

Leading market research company Facts & Factors (FnF) published the latest research report onHemophilia Treatment Market By Product (Desmopressin, Antifibrinolytic Agents, Plasma Derived Coagulation Factor Concentrates, and Recombinant Coagulation Factor Concentrates), By Disease (Hemophilia A, Hemophilia B, Hemophilia C, and Others), By Therapy (Replacement Therapy, ITI Therapy, Gene Therapy, and Antibody Therapy), By Treatment Type (On-demand and Prophylaxis), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others), And By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 20202026in its database which covering in-depth analysis of size, segmentation market growth, and market share, competitive Landscape, Detailed List of Key Buyers and End-Users.

This report focuses on theHemophilia Treatment marketwhich is experiencing strong growth. The report gives a guide to the Hemophilia Treatment market which will be shaping and changing our lives over the next six years and beyond, including the markets response to the challenge of the global pandemic.

Request an Exclusive Free Sample Report of Hemophilia Treatment Market:https://www.fnfresearch.com/sample/global-hemophilia-treatment-market-by-product-desmopressin-antifibrinolytic-790

(The sample of this report is readily available on request).

Benefits of Requesting a FREE Sample Report Before Purchase:

(Note: The sample of this report is updated with COVID-19 analysis before delivery)

Spreadsheet Chapters May include

Market Consumption in US$ by Country by Product/Service by Year. Market, Financial, Competitive, Market Segmentation, Industry, Critical Parameters, Marketing Costs, Markets, Decision Makers, Performance, Product Launch.

Some of Following Top Market Players Profile Included in This Report:

Hemophilia Treatment Market Analysis by Leading Market Players

Leading top market players in the Hemophilia Treatment market are analyzed in the report along with their business overview, operations, geographical locations, financial analysis, SWOT profile, and Carbon Black products & services.

COVID-19- Current Scenario, Potential Impact, and Strategic Situation Analysis

Various communities and companies are doing their best to function and perform, and eventually cope with the challenges raised by COVID-19 pandemic. The COVID-19 pandemic had a negative impact on the market size for the year 2020, with small and medium scale companies struggling to sustain their businesses in the near term future. Industry leaders are now focusing to create new business practices to deal with crisis situations like COVID-19 pandemic.

Enquire About COVID-19 Updates for This Report:https://www.fnfresearch.com/inquiry/global-hemophilia-treatment-market-by-product-desmopressin-antifibrinolytic-790

The report covers market characteristics, market size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the markets historic and forecast market growth by geography. It places the market within the context of the wider Hemophilia Treatment market, and compares it with other markets.

The report contains a deep analysis of the Hemophilia Treatment market with size in terms of both value and volume. The report provides a clear insight into current and future developments of the Hemophilia Treatment market. It provides essential insights into Hemophilia Treatment market revenue for the top 21 regional and national, and forecast until 2026.

Request Customized Copy of Report @https://www.fnfresearch.com/customization/global-hemophilia-treatment-market-by-product-desmopressin-antifibrinolytic-790

(We customize your report according to your research need. Ask our sales team for report customization.)

Free Customization

This report includes Free Customization which generally involves a breakout of particular industries or country data at no additional charge. An analyst call can be arranged as part of this which is included in the free customization offering. The Hemophilia Treatment Market can be customized to the country level or any other market segment.

The report concludes with the profiles of the key players in the Hemophilia Treatment market. The key players are evaluated on various parameters such as business overview, development, sales value analysis, and recent development. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology, and recent development.

For More Report Details, Visit:https://www.fnfresearch.com/global-hemophilia-treatment-market-by-product-desmopressin-antifibrinolytic-790

KEY REPORT POINTERS & HIGHLIGHTS:

About Us:

Facts & Factorsis a leading market research company and offers customized research reports and consulting services. Facts & Factors aims at management consulting, industry chain research, and advanced research to assist our clients by providing planned revenue model for their business. Our report and services are used by prestigious academic institutions, start-ups, and companies globally to understand the international and regional business background. Our wide-ranging database offers statistics and detailed analysis of different industries worldwide that help the clients in achieving sustainable progress. The well-organized reports help clients in developing strategies and making informed business decisions.

Contact Us:

Facts & Factors

A 2108, Sargam,

Nanded City,

Sinhagad Road,

Pune 411041, India

USA: +1-347-989-3985

E-Mail:sales@fnfresearch.com

Web:https://www.fnfresearch.com

Read the original post:
Hemophilia Treatment Market Size & Share 2020 Research Report Covering COVID-19 Impact on Growth Analysis and Outlook till 2026 - Red & Black...

3 Top Healthcare Stocks to Buy Right Now – The Motley Fool

Investors often consider the healthcare sector a "defensive" one because people get sick in good economic times and bad. Thus, the stocks tend to hold up in times when worries about the economy abound.

That maxim has pretty much been tossed out the window in 2020, along with much of conventional investing wisdom. The healthcare sector has been thrown into turmoil with stay-at-home orders and clinic closures. But biotech stocks have been doing very well, with the iShares NASDAQ Biotechnology ETF (NASDAQ:IBB) up 16% this year.

For investors looking for places to put money in the midst of uncertainty about the direction of the pandemic, stocks of companies in the forefront of important medical advances hold promise for the long term. BioNTech(NASDAQ:BNTX), NeoGenomics (NASDAQ:NEO), and Illumina (NASDAQ:ILMN) are three companies that should come through the pandemic era stronger than ever.

Image source: Getty Images.

Stocks that are in the race for a COVID-19 vaccine have seen their shares soar in the past four months, but German biotech BioNTech is still a good buy for the long term. Despite a big partner for the vaccine in Pfizerand an approach based on the same technology as Moderna's, shares haven't risen as far as those of Moderna, and BioNTech's market capitalization is only two-thirds of it.

BioNTech is differentiated from its competitors in that it has four vaccines for the SARS-CoV-2 virus, each with a unique messenger RNA (mRNA) format, in clinical tests designed to quickly narrow down to the most promising candidate. On July 1, the company and Pfizer reported very positive results from a phase 1/2 trial of one of the four candidates, saying that the blood concentration of neutralizing antibodies in the subjects were up to 2.8 times higher than in patients who had recovered from the virus. Still to come soon are results from the three other candidates, and the company expects to start a phase 2b/3 study this month with 30,000 participants.

But the reason to buy BioNTech for the long term isn't for a COVID-19 vaccine, although a win there would be a strong catalyst. The more important driver for the company's business is the company's rich pipeline of next-generation cancer immunotherapies. The company has 10 anti-cancer drugs in 11 clinical trials targeting melanoma and cancers of the breast, ovaries, prostate, pancreas, head and neck, and other solid tumors. BioNTech should produce a steady news flow of results from these trials in the coming months. Success is not a sure thing, but if the news is good, the stock should have a strong tailwind.

The pandemic caused hospitals and health centers to postpone elective medical procedures, but what was a little surprising was that even companies that provided services needed to treat severe diseases such as cancer saw a drop in business as the stay-at-home orders went into effect. NeoGenomics is the largest pure-play oncology testing company and saw its clinical test volume drop 20% year over year in the last two weeks of March and between 25% and 30% in April.

NeoGenomics is in a sweet spot in healthcare. Oncology is by far the largest area of investment among drug companies, with 40% of all U.S. clinical development spending going to cancer drug trials, about three times the amount for the therapy area in second place. Driving the industry are new approaches to therapies that target malignancies based on the specific biochemistry and genetics of different cancers. As medicines become more specific, testing becomes an increasingly important part of treatment, and NeoGenomics is growing sales both to clinicians working with cancer patients and to pharmaceutical companies developing new drugs.

NeoGenomics' business should bounce back quickly even if the pandemic resurges, given the urgency of treatment for seriously ill cancer patients. The company didn't furlough employees when the business dipped, so as to be better prepared for the rebound it expects. Revenue growth in the first quarter dipped to 11% after jumping 40% in the fourth quarter, and analysts are actually expecting a 15% decline in revenue when the company reports second-quarter results on July 28. The company continues to expect long-term organic growth in the mid-teens and will probably continue to grow by acquisition as well.

Investors have been buying the stock in recent weeks, after the company launched a new suite of liquid biopsy tests, enabling the detection of cancer biomarkers from blood samples when tissue specimens of solid tumors are hard to obtain. Low expectations in the near term, strong growth prospects for the long term, and the ability to innovate through internal development and partnerships make the stock a buy for patient investors.

Illumina dominates the market for gene sequencers, and even though COVID-19 research drove up sales of gene sequencing systems in the first quarter, the company expected sequential declines in revenue in every region in the second quarter. Shutdowns of research institutions and clinics should take a toll on the company's results, which will be reported on Aug. 3.

But longer term, the company is in great shape. The use of genetic information in the diagnosis and treatment of disease is accelerating, while large-scale population studies just getting under way when the pandemic hit will eventually drive big increases in sales of the supplies used in operating Illumina's instruments.

Illumina's business tends to follow the company's cycle of new product introductions. The launch of a major new platform, such as the mid-range sequencers the company announced in January, can cause a temporary slowing of sales as customers stop buying older models, but then it can fuel a strong, multi-year surge in growth as higher sequencing speeds at lower costs draw in new customers. That scenario appears to be playing out this year, with first-quarter revenue up only 2% because of soft system sales, but with almost half of early sales of the new NextSeq 2000 system going to customers who were buying their first Illumina product.

Gene sequencing produces massive amounts of data, so Illumina directs some of its investment to tools that help clinicians and researchers make sense of it all. The company this month launched new software to help detect genetic diseases from genomic information and last month acquired Dutch software company BlueBee, maker of cloud software for interpreting genomic data.

Illumina should emerge from the COVID-19 era stronger than ever, and its latest new products should give the company a boost going into 2021.

Excerpt from:
3 Top Healthcare Stocks to Buy Right Now - The Motley Fool